TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026
Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity for Prediction of Postprophylaxis CMV Disease in a Phase 3 Trial of Letermovir Versus Valganciclovir Prophylaxis in Donor CMV-Seropositive/Recipient CMV-Seronegative Kidney Transplant Recipients.
Ajit P Limaye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.